Synonyms: Taigexyn® | TG-873870 | TG873870
nemonoxacin is an approved drug (Taiwan (2014))
Compound class:
Synthetic organic
Comment: Nemonoxacin is a non-fluorinated quinolone antibacterial with broad-spectrum activity against Gram-positive and Gram-negative bacteria and atypical pathogens, including methicillin-resistant S. aureus (MRSA) and vancomycin-resistant pathogens [1-2]. It selectively inhibits bacterial DNA topoisomerase (DNA gyrase) activity.
|
|
No information available. |
Summary of Clinical Use |
Nemonoxacin can be administered orally or parenterally. It has completed Phase 3 clinical trials for community-acquired pneumonia (CAP). Oral nemonoxacin has been approved in Taiwan for the treatment of CAP in adults [4]. |
Clinical Trials | |||||
Clinical Trial ID | Title | Type | Source | Comment | References |
NCT02205112 | A Phase III Study to Evaluate the Efficacy and Safety of Intravenous Infusion of Nemonoxacin in Treating CAP | Phase 3 Interventional | TaiGen Biotechnology Co., Ltd. |